The McKinsey article discusses the benefits and challenges of decentralizing clinical trials, accelerated by the COVID-19 pandemic. Decentralized trials bring trial activities closer to patients using virtual tools, improving access, convenience, and patient engagement. Key enablers include digital health technology, patient-centric designs, and regulatory support. However, challenges such as data quality, patient and site adaptability, regulatory alignment, and internal change management must be addressed for successful implementation.
Findd’s software can support this by providing precise time tracking, resource management, and ensuring compliance, thereby enhancing the efficiency of decentralized trial operations.